Cargando…
Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report
Herein, we present a case report of sintilimab treatment for a patient with ureteral cancer reoccurring after bladder cancer, and exploration of the mechanism of adverse reactions from the aspects of intestinal flora and immunity. We have reported a case of leukopenia in a patient with recurrent ure...
Autores principales: | Zhong, Zhixian, Wang, Zhiying, Li, Yun, Zhong, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899141/ https://www.ncbi.nlm.nih.gov/pubmed/35280656 http://dx.doi.org/10.21037/tau-21-1146 |
Ejemplares similares
-
Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events
por: Tu, Lingfang, et al.
Publicado: (2021) -
Sintilimab: Pneumonitis: case report
Publicado: (2021) -
EDP-M plus sintilimab in the treatment of adrenocortical carcinoma: a case report
por: Zhang, Zhipeng, et al.
Publicado: (2022) -
The whole treatment process and thinking of a patient with NUT carcinoma of the parotid gland: a case report
por: Fu, Shujuan, et al.
Publicado: (2023) -
Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report
por: Lin, Sen, et al.
Publicado: (2022)